Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Symbioflor Bronchoprotect
- Development stage
- Phase 4
- Lead developer
- Max Zeller Söhne
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Symbioflor Bronchoprotect is an over-the-counter (OTC) probiotic medicine developed and manufactured by Max Zeller Söhne AG. [1] It is classified as an immunostimulant, containing a bacterial concentrate of live Enterococcus faecalis (strain DSM 16440). [1, 2, 8] The product is indicated for reducing the recurrence rate of infections of the upper and lower respiratory tract, particularly sinusitis and bronchitis. [1, 2, 3] It functions by modulating the body's immune system; the bacteria are thought to 'train' the immune cells located in the gut, which constitute a significant portion of the body's immune system. [1, 4] This stimulation leads to the production of antibodies that are then transported to the mucous membranes of the respiratory system, enhancing their defensive capabilities against pathogens. [1] Symbioflor Bronchoprotect is administered as oral drops. [2]
- Brand names
- Symbioflor Bronchoprotect
- Other names
- E. faecalis Symbio bacterial lysateEnterococcus faecalis Symbioflor 1
Beyond the preview
Go deeper on Symbioflor Bronchoprotect.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Symbioflor Bronchoprotect.